BLLN
Price
$89.92Alerts
Change
-$0.28 (-0.31%)
Updated
Nov 20 closing price
Capitalization
5.38B
Intraday BUY SELL Signals
NTRA
Price
$273.40Alerts
Change
-$16.52 (-5.70%)
Updated
Nov 20 closing price
Capitalization
44.78B
103 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BLLN vs NTRA

BLLN vs NTRA Comparison Chart in %
View a ticker or compare two or three
VS
BLLN vs. NTRA commentary
Nov 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLLN is a Hold and NTRA is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BLLN with price predictions
Nov 20, 2026

BLLN sees MACD Histogram crosses below signal line

BLLN saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 12, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 10 instances where the indicator turned negative. In 9 of the 10 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BLLN as a result. In 18 of 21 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.

BLLN moved below its 50-day moving average on November 13, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BLLN crossed bearishly below the 50-day moving average on November 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 2 of 2 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BLLN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

The Aroon Indicator for BLLN entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where BLLN advanced for three days, in 48 of 54 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.

BLLN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 43 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. BLLN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.016) is normal, around the industry mean (67.298). BLLN has a moderately high P/E Ratio (136.508) as compared to the industry average of (4.239). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (12.195) is also within normal values, averaging (9.775).

The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BLLN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

A.I.Advisor
a Summary for NTRA with price predictions
Nov 20, 2026

NTRA in downward trend: price dove below 50-day moving average on November 05, 2026

NTRA moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend. In 26 of 33 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NTRA as a result. In 69 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 72%.

The Moving Average Convergence Divergence Histogram (MACD) for NTRA turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 31 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 63%.

The 10-day moving average for NTRA crossed bearishly below the 50-day moving average on November 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 62%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NTRA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

The Aroon Indicator for NTRA entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +0.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where NTRA advanced for three days, in 247 of 308 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

NTRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (24.585) is normal, around the industry mean (67.298). NTRA's P/E Ratio (-230.126) is considerably lower than the industry average of (4.239). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (17.857) is also within normal values, averaging (9.775).

The Tickeron Seasonality Score of 8 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 40 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating fairly steady price growth. NTRA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 72 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
NTRA: Fundamental Ratings
NTRA
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
40
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
72
SEASONALITY SCORE
1..100
8

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BLLNNTRA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 13 days ago
89%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 5 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
COMPARISON
Comparison
Nov 21, 2026
Stock price -- (BLLN: $89.92 vs. NTRA: $273.40)
Brand notoriety: BLLN and NTRA are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLLN: 118% vs. NTRA: 77%
Market capitalization -- BLLN: $5.38B vs. NTRA: $44.78B
BLLN [@Medical Specialties] is valued at $5.38B. NTRA’s [@Medical Specialties] market capitalization is $44.78B. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The average market capitalization across the [@Medical Specialties] industry is $20.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLLN’s FA Score shows that 0 FA rating(s) are green while NTRA’s FA Score has 1 green FA rating(s).

  • BLLN’s FA Score: 0 green, 5 red.
  • NTRA’s FA Score: 1 green, 4 red.
According to our system of comparison, NTRA is a better buy in the long-term than BLLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLLN’s TA Score shows that 4 TA indicator(s) are bullish while NTRA’s TA Score has 4 bullish TA indicator(s).

  • BLLN’s TA Score: 4 bullish, 6 bearish.
  • NTRA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both BLLN and NTRA are a bad buy in the short-term.

Price Growth

BLLN (@Medical Specialties) experienced а -14.48% price change this week, while NTRA (@Medical Specialties) price change was -14.32% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -9.90%. For the same industry, the average monthly price growth was -17.15%, and the average quarterly price growth was +16.33%.

Reported Earning Dates

NTRA is expected to report earnings on Mar 04, 2027.

Industries' Descriptions

@Medical Specialties (-9.90% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

View a ticker or compare two or three
Interact to see
Advertisement

BLLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLLN has been loosely correlated with ADPT. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if BLLN jumps, then ADPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLLN
1D Price
Change %
BLLN100%
-0.31%
ADPT - BLLN
35%
Loosely correlated
-0.43%
NTRA - BLLN
32%
Poorly correlated
-5.70%
GH - BLLN
29%
Poorly correlated
+0.16%
PSNL - BLLN
28%
Poorly correlated
-3.06%
ILMN - BLLN
28%
Poorly correlated
-3.90%
More

NTRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTRA has been loosely correlated with GH. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if NTRA jumps, then GH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRA
1D Price
Change %
NTRA100%
-5.70%
GH - NTRA
60%
Loosely correlated
+0.16%
NEO - NTRA
53%
Loosely correlated
-1.79%
ISRG - NTRA
53%
Loosely correlated
-2.01%
ADPT - NTRA
52%
Loosely correlated
-0.43%
TMO - NTRA
50%
Loosely correlated
-2.79%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NCDL11.25-0.07
-0.62%
Nuveen Churchill Direct Lending Corp
ADMA13.17-0.17
-1.27%
ADMA Biologics
ICLR186.71-3.65
-1.92%
ICON plc
NINE5.80-0.52
-8.23%
Nine Energy Service Inc.
AQMS0.65-0.31
-32.27%
Aqua Metals Inc